BB
Benjamin Burnett Wells Fargo Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
29
Avg Return
Past Year
Past Year
21%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
84.2%
Neutral
15.8%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $193 |
9%
upside
| 2 | +13% |
0
%
| 13 Jan ‘26 5 days ago |
|
|
|
Overweight
Maintained
| $45 |
100%
upside
| 1 | +14% |
0
%
| 30 Dec ‘25 19 days ago |
|
|
|
Overweight
Maintained
| $9 |
55%
upside
| 1 | -4.7% |
0
%
| 18 Dec ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $234 |
45%
upside
| 1 | -18% |
0
%
| 16 Dec ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $48 |
20%
upside
| 2 | +0.77% |
0
%
| 11 Dec ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $29 |
112%
upside
| 2 | +68% |
0
%
| 9 Dec ‘25 1 month ago |
|
|
|
Equal-Weight
Maintained
| $22.50 |
5%
upside
| 2 | – |
–
| 20 Nov ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $35 |
58%
upside
| 2 | +11% |
0
%
| 13 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $37 |
17%
upside
| 2 | +2.5% |
0
%
| 13 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $8 |
54%
upside
| 1 | -3.9% |
0
%
| 11 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $23 |
22%
upside
| 1 | +11% |
0
%
| 11 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $93 |
28%
upside
| 1 | +7% |
0
%
| 5 Nov ‘25 2 months ago |
|
|
|
Equal-Weight
Maintained
| $423 |
9%
downside
| 1 | – |
–
| 30 Oct ‘25 2 months ago |
|